Therapeutic Action
Steroidal anti-inflammatory drug (inhaled corticosteroid)
Source page 54
Loading InternPractice…
Individual generic drug information
Extracted information for BECLOMETASONE only.
Steroidal anti-inflammatory drug (inhaled corticosteroid)
Source page 54
Long term treatment of chronic asthma (maintenance and symptomatic treatment), alone or in combination with a beta-2 agonist bronchodilator
Source page 54
Extracted information for BECLOMETASONE only.
Do not administer to patients with untreated respiratory infection. May cause: throat irritation, hoarseness and cough at the beginning of treatment; oro-pharyngeal candidiasis; adrenal suppression with high doses for prolonged periods. Pregnancy: no contra-indication Breast-feeding: no contra-indication
Source pages 55, 56
Extracted information for BECLOMETASONE only.
Solution or suspension for inhalation in pressurised metered dose inhalers, delivering 50, 100 or 250 micrograms of beclometasone dipropionate/puff
Source page 54
Start at the step most appropriate to initial severity. Always try to administer the lowest effective dose. Asthma 6 to 11 years 12 years and over and adult severity Intermittent Only when symptomatic: asthma _ 200 to 500 micrograms, in combination with salbutamol Mild 50 to 100 micrograms (low dose) 100 to 250 micrograms (low dose) persistent 2 times daily 2 times daily asthma Moderate 50 to 100 micrograms (low dose) 100 to 250 micrograms (low dose) persistent 2 times daily, in combination with 2 times daily, in combination with asthma salmeterol salmeterol OR (if salmeterol is not available) OR (if salmeterol is not available) 150 to 200 micrograms (medium dose) 300 to 500 micrograms (medium dose) 2 times daily 2 times daily Severe 150 to 200 micrograms (medium dose) 300 to 500 micrograms (medium dose) persistent 2 times daily, in combination with 2 times daily, in combination with asthma salmeterol salmeterol OR (if salmeterol is not available) > 500 micrograms (high dose) 2 times daily In all cases, do not exceed 2000 micrograms daily.
Source pages 54, 55
As long as required. Re-evaluate after 2 to 3 months if doses are adequate or need to be increased or decreased.
Source page 55
Shake the inhaler. Remove the mouthpiece cover. Breathe in and breathe out as completely as possible. Place the lips tightly around the mouthpiece. Inhale deeply while activating the inhaler. Hold breath 10 seconds before exhaling. If hand-breath co-ordination is difficult, use a spacer to facilitate administration and improve the efficacy of treatment.
Source page 55
Extracted information for BECLOMETASONE only.
When beclometasone is given with salbutamol, preferably use combination inhaler. If not available, beclometasone should be inhaled right after salbutamol. Relief of symptoms may require several days or weeks of continuous therapy. Clean the mouthpiece before and after each use. Do not pierce or incinerate used aerosol containers (risk of explosion). Also comes in a combination metered dose inhaler with formoterol.
Source page 56
– Below 25 °C
Source page 56
Filter the extracted dose blocks for this individual drug.